About the Event
You Missed the Only Event Dedicated to Optimizing ADC Process Development & Accelerating Manufacturing to Stay Ahead of Shortening Timeframes
As the ADC industry grows more competitive and manufacturing timelines get shorter, don’t let your processes hold you back.
Returning for a second year, the ADC Process Development Summit boasted three jam-packed days of novel presentations, roundtable discussions and interactive workshops, all tailored to provide cutting-edge insights to help attendees enhance the yield, purity and homogeneity of your ADC processes.
Pioneers of the field navigated CQA setting and regulatory control strategies, unlocking maximum conjugation yield to decrease heterogeneity, optimized purification processes to increase process robustness, and evaluated how to handle deviation challenges in ADC manufacturing.
You missed a highly focused audience with the likes of AstraZeneca, Bristol Myers Squibb, Pfizer, Exelixis, Johnson & Johnson, Gilead and AbbVie and in-depth discussions that empowered attendees with practical take-home lessons to revolutionize ADC manufacturing processes.
2024 Summit Key Benefits:
Minimize unit operations and costs by perfecting tangential flow filtration with Pfizer and dive into Gilead’s cutting-edge non-chromatographic purification techniques.
Propel your process development scale-up with Johnson & Johnson, fine-tuning specifications, streamlining processes, and prepping for seamless outsourcing.
Accelerate drug product development with AstraZeneca and Exelixis, unlocking advanced stability insights and ensuring process robustness for unmatched success.
Who Did You Miss?
The 2nd ADC Process Development Summit bought together a community of industry experts, to facilitate an in-depth discussion, purpose built for those working in process development, conjugation, purification, control, CMC and engineering.
Aimed at both Directors overseeing the entire process and manufacturing lifecycle all the way through to hands-on scientists, this is the only conference that provides an intimate forum for technical and strategic discussion for those that prioritize optimizing their ADC manufacturing processes.
With practical applicability at the heart of the summit, attendees left ready to impact day-to-day roles and optimize both your current and future process development.
What Were the 2024 Speakers Are Excited About:
“I’m thrilled about ADCs and their promising future. These drugs have significantly benefited patients, even when other cancer therapies might not have been safe. Regarding the summit, the focused group setting provides an excellent opportunity to connect with remarkable individuals and learn from their experiences.”
“ADC therapeutics could be a way to tackle critical unmet need in Oncology. The recent approvals is a testimony to this end. ADC development and manufacturing however present new challenges and it is fascinating to be able to tackle and solve the associated issues”
“The ADC Process Development Summit is an exciting opportunity to share insights and have great discussions with colleagues related to our shared interest of antibody-drug conjugates.”
